SCHEMBL493215

SCHEMBL493215

O=C(O)CN(C1CC1)S(=O)(=O)c1c(Cl)cc(Cl)cc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.40
SLC6A9 P48067 1/20 0.40
ALDH1A1 P00352 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CNR1 P21554 1/20 0.39
KMT2A Q03164 3/20 0.38
USP2 O75604 3/20 0.37
TSHR P16473 2/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
MEN1 O00255 2/20 0.37
HDAC6 Q9UBN7 3/20 0.36
HDAC8 Q9BY41 2/20 0.36
HDAC11 Q96DB2 1/20 0.36
MAPT P10636 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
DAGLA Q9Y4D2 1/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL493246 0.81 TBXA2R (0.36) MAPK1CNR1USP2HDAC6HDAC8
SCHEMBL493599 0.81 KMT2A (0.44) MAPK1ALDH1A1L3MBTL1CNR1KMT2A
SCHEMBL1935801 0.73 HDAC6 (0.36) MAPK1CNR1TSHRHDAC6HDAC8
SCHEMBL937908 0.72 MEN1 (0.48) MAPK1KMT2AUSP2TSHRMEN1
SCHEMBL4030931 0.71 HTT (0.44) ALDH1A1CNR1KMT2AMEN1HDAC6
SCHEMBL13495550 0.71 HDAC6 (0.36) MAPK1CNR1TSHRHDAC6HDAC8
SCHEMBL493994 0.71 STS (0.35) MAPK1ALDH1A1CNR1PSEN1PSEN2
SCHEMBL5114179 0.69 PSEN1 (0.44) CNR1HDAC6HDAC8HDAC11DAGLA
SCHEMBL3968836 0.67 NPSR1 (0.58) MAPK1SLC6A9ALDH1A1L3MBTL1KMT2A
SCHEMBL3909934 0.64 ALDH1A1 (0.67) MAPK1ALDH1A1L3MBTL1CNR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD MAPK1 3395/4885SLC6A9 3088/4885ALDH1A1 1349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.